Fangge Pharmaceutical successfully participated in the "Ganoderma lucidum helps prevent epidemics and promotes the high-quality development of the industry" forum and the 2021 annual meeting of the Ganoderma lucidum Professional Committee of the Chinese Medicine Association
In order to better promote the high-quality development of my country's Ganoderma lucidum industry, the “Ganoderma lucidum helps epidemic prevention and high-quality development of the industry” forum hosted by the Ganoderma lucidum Professional Committee of the China Association of Chinese Medicine and the 2021 Annual Meeting of the Ganoderma lucidum Professional Committee of the China Association of Chinese Medicine will be held from May 15th to 16th. It was successfully held in Kaiping City, Guangdong Province, the famous hometown of overseas Chinese in China.
The conference invited leaders from the Ganoderma lucidum Professional Committee of the Chinese Medicine Association, local government representatives, Peking University, Tsinghua University, Chinese Academy of Medical Sciences, Shanghai Academy of Agricultural Sciences and other related scientific research institutes and representatives of various enterprises to gather together to exchange and share the development of Ganoderma lucidum industry The research results of Ganoderma lucidum will promote and help the development of the Ganoderma lucidum industry together!
At the opening ceremony, Fang Shuting, former deputy director of the State Administration of Traditional Chinese Medicine, former chairman of the China Association of Chinese Materia Medica, and director of the expert committee, honorary chairman of the Ganoderma lucidum committee of the Chinese Association of Chinese Materia Medica, former vice president of Beijing Medical University, and professor of Peking University School of Basic Medicine Lin Zhibin, Chairman of the Ganoderma lucidum Special Committee of China Association of Chinese Materia Medica, Yang Baoxue, Deputy Dean of Peking University School of Basic Medicine and other leaders delivered speeches in turn, highly affirming the role played by the Ganoderma lucidum industry in the new crown epidemic and expounding the Ganoderma lucidum industry in the "14th Five-Year Plan" The opportunities and challenges faced in the first year of the strategic plan, and summarized the current status of the development of the Ganoderma lucidum industry across the country. While affirming its achievements, it also expressed wishes for the development and growth of the Ganoderma lucidum industry, and wished the conference a complete success.
In the academic report, the honorary chairman of the Ganoderma lucidum Special Committee of the Chinese Medicine Association, former vice president of Beijing Medical University, professor Lin Zhibin of Peking University School of Basic Medicine, professor Wang Zhao of Tsinghua University, professor Yang Baoxue of Peking University and other experts and scholars named "Ganoderma lucidum helps epidemic prevention "Theory and Practice of Emotion" as the theme, and launched the research on "Ganoderma lucidum to strengthen the body and remove the evil, strengthen immunity and resist viral infection", "Research progress on the immunomodulatory effect of Ganoderma lucidum compound", "Pharmacology and clinical research of the anti-inflammatory effect of Ganoderma lucidum", "Discussion on the development of Ganoderma lucidum industry-looking at the development of Ganoderma lucidum industry through the practice of Panax notoginseng", "Big Data Analysis Report of Domestic Ganoderma lucidum Industry in 2021" and other reports provide comprehensive interpretations to provide suggestions for the Ganoderma industry and establish new ideas for the development of the Ganoderma lucidum industry ".
Zhejiang Fangge Pharmaceutical Co., Ltd., as the vice chairman unit of the Lingzhi Professional Committee of China Association of Chinese Materia Medica, participated in this meeting as the only representative of Qingyuan's edible fungus industry and gave a speech
Zhejiang Fangge Pharmaceutical Co., Ltd. is located in Qingyuan, Zhejiang. It is the only biomedical technology enterprise under Hu Qingyutang that focuses on the R&D and production of edible and medicinal fungi. Relying on Qingyuan’s unique ecological environment and the advantages of authentic resources of edible and medicinal fungi, it has established a relatively complete bioengineering system and Industrial application system; a strict quality management system and a relatively complete independent research and development and industry-university-research cooperation system have been established.
As the "Ganoderma" authentic medicinal material science popularization station and the vice chairman unit of the Ganoderma lucidum Professional Committee of China Association of Chinese Materia Medica, it strives to cure and innovate on this important branch of the application of Ganoderma industry, seize major opportunities, give full play to late-comer advantages, and win the market and consumption. It has developed a series of Ganoderma lucidum products: broken wall Ganoderma lucidum spore powder, Ganoderma lucidum Schisandra capsules, Red yeast rice and salvia Ganoderma capsules.
This conference is a grand event full of dry goods and a multi-dimensional sharing. Fangge Pharmaceutical actively follows General Secretary Xi’s Healthy China strategy in the development process, focusing on the excavation and innovation of fungal medicine resources, and will continue in the future: serving the health of the whole people as its own responsibility, guided by market demand, and not forgetting its original intentions , Constantly innovate, expand and strengthen the Ganoderma lucidum industry, and let Ganoderma lucidum help more people get health and make their due contributions.
